Reference No: BP0408(B)Pages: 21Published on: 20, December, 2017
Abstract: India’s diagnostics business valued at USD 10 billion was growing at 20% annually. Several players with different business models competed. Dr. Lal PathLabs, the world’s largest histopathology centre led with a menu of 3,500 tests, 1,600 collection centres and 7,000 pick-up points. Its Initial Public Offer had been oversubscribed 33.41 times and the team ... More
Reference No: BP0408(A)Pages: 8Published on: 20, December, 2017
Abstract: Diagnostics services in India were growing at 20% annually with billing of USD 3.4 billion. With WTO’s GATS, foreign competition was arising. Dr. Lal PathLabs had formidable brand recognition and Dr. Arvind Lal was wondering whether to accept private equity and induct management professionals to keep pace with competitors through acquisitions ... More
